MediGuide-assisted atrial flutter ablation in a patient with a HeartMate II left ventricular assist device

Thanh, Hien Kiem Nguyen; Andrade, Jason G.; Dyrda, Katia; Thibault, Bernard; Khairy, Paul; Macle, Laurent

doi:10.1016/j.hrcr.2015.03.008

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the largest series, eight patients with AFL, rapid ventricular response, and evidence of right ventricular failure underwent AFL ablation with improvement of right ventricle failure and resolution of inappropriate implantable cardioverter defibrillator shocks [13]. Outside of this report, two case reports describe ablation of AFL and pulmonary vein isolation for management of atrial arrhythmias causing rapid ventricular rates and decompensated heart failure [32,33]. Therefore, while ablation of AFL may be reasonable when rapid ventricular rates cause clear symptomatic or hemodynamic decompensation, there is no evidence that broader attempts at rhythm control therapy are beneficial.…”

Section: Rhythm Versus Rate Controlmentioning

confidence: 99%

Atrial arrhythmias in patients with left ventricular assist devices

Özcan¹,

Deshmukh

2020

Current Opinion in Cardiology

View full text Add to dashboard Cite

Purpose of review-Atrial arrhythmias commonly occur in patients with advanced heart failure with reduced ejection fraction (HFrEF) who require left ventricular assist devices (LVADs) implantation. This review summarizes the current literature regarding the incidence, prevalence, and predictors of atrial arrhythmias in LVAD patients and its impact on the clinical outcomes. Moreover, we review the mechanisms and management strategies of atrial arrhythmias in this population.Recent findings-Atrial arrhythmias including atrial fibrillation, atrial flutter, and atrial tachycardia are highly prevalent in patients with advanced HFrEF before or after the LVAD implantation. Atrial arrhythmias have a significant impact on overall clinical outcome including survival, heart failure hospitalization, quality of life, thromboembolic events and resource utilization. Atrial fibrillation and other atrial arrhythmias frequently coexist in this population. In patients with atrial arrhythmias and LVAD, anticoagulation and cardiovascular implantable electronic devices should be closely monitored and managed to prevent thromboembolic events or inappropriate shocks. Rhythm and rate control strategies are comparable regarding overall clinical outcomes in this population. LVADs induce favorable atrial remodeling in patients with HFrEF.Summary-Atrial arrhythmias are highly common in LVAD patients and have significant impact on overall clinical outcomes. Further studies are needed to determine optimal management and prevention of atrial arrhythmias in LVAD population.

show abstract

Section: Rhythm Versus Rate Controlmentioning

confidence: 99%